Search results
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga· 3 days agoA Delaware federal jury has determined that AstraZeneca Plc AZN must pay Pfizer Inc PFE $107.5...
Pfizer to Cut Costs in Multi-Year Effort — Update
Morningstar· 2 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio enhancements. The first ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 7 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 6 days ago, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding that...
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
The Motley Fool via AOL· 4 days agoIf you have an extra $100 to invest, you could set yourself up with dividends from Realty Income...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 1 day agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in ...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AOL· 6 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 7 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Pfizer Tax Practices Targeted by Congress in Wider Pharma Probe
Bloomberg Law· 3 days agoSenate Finance Chair Ron Wyden (D-Ore.) demanded information into the tax practices of Pfizer Inc., expanding his panel’s probe into the profit-shifting practices of US pharmaceutical companies.
Pfizer Targets $1.5 Billion in Savings by 2027 as It Streamlines Operations
US News & World Report· 2 days agoThe program will include operational efficiencies, network structure changes, and product portfolio enhancements, the company said. It expects to realize some cost savings from the program in ...